TRUMP RED-HOT DINNER with VACCINES’ BIG PHARMAs! Pfizer CEO found “Goos Relationship” in the Meeting with RFK jr and next US President
Introduction by Fabio Giuseppe Carlo Carisio
A red-hot dinner now destined to stir up a hornet’s nest of controversy. It is the one had by the future president of the USA Donald Trump together with some CEOs of the Big Pharma of Vaccines.
We mentioned it on Gospa News in a previous investigation on the mRNA genetic serums prepared by Moderna even before the discovery of the first outbreaks of Covid but we did not want to give excessive weight to this diplomatic meeting.
Now, however, all the mainstream and counter-information newspapers are writing about it because Albert Bourla, CEO of Pfizer in the eye of the storm for an investigation by the European Prosecutor’s Office EPPO on secret deals on the purchase of Covid vaccines with his friend Ursula Von Der Leyen, president of the European Commission, boasted of having found new friends in Trump and in the lawyer Robert F. Kennedy jr, until a few weeks ago a pugnacious NO-VAX, who seems to have converted a bit to VACCINOPOLI on the way to Washington…
These rumors, which may have been spread on purpose by Bourla and the mainstream to revive Pfizer’s business in crisis due to the flop of the latest Covid boosters and the lawsuit filed by GSK controlled by Bill Gates on their patent, have revived Gospa News’ suspicions.
We were the first, in fact, to report the alleged betrayal of RFK jr when he decided to support Trump’s candidacy despite the fact that the choice of James David Vance as vice-president had just been announced.
Vance is in fact intrigued both with the Pentagon, among the first financiers of Moderna thanks to the supervision of the infamous virologist Anthony Fauci, but also in a company that is developing research on gene therapies similar to mRNA genetic serums.
Trump’s subsequent choice, after his victory in the November presidential elections, to appoint Big Pharma lobbyist Suzie Wiles as White House Chief of Staff raised further suspicions, only attenuated by the subsequent announcement of the future US president’s desire to indicate Robert F. Kennedy Jr. as his Secretary of Department of Health and Human Services.
Now this dinner becomes a third disturbing clue. For the detective Hercule Poirot invented by Agatha Christie in her detective stories, it would already be proof of a New World Order conspiracy. We still want to hope, for the good of humanity now exposed to the new nightmare Disease X, that it is not…
Below we report two articles with opposite views of the event.
That of the director of Health Impac News, a famous and careful site of investigations on vaccine damage, and Fierce Pharma, a reference newspaper for pharmaceutical companies.
Fabio Giuseppe Carlo Carisio
Robert F. Kennedy Jr. Betrays Entire “Health Freedom” Movement for Personal Gain
by Brian Shilhavy – originally published on Health Impact News
Robert F. Kennedy, Jr. was invited to a dinner party with President-elect Donald Trump last week, where he met with executives from Big Pharma, including Robert Bourla, the CEO of Pfizer, who made $billions under Trump’s first term, by securing from Trump an FDA emergency-use authorization for the first COVID-19 injections for the U.S., along with exclusive distributor rights in Israel for Pfizer’s deadly COVID-19 “vaccine.” Also attending the dinner at Trump’s residence in Florida was his Chief of Staff, Susie Wiles, who is also a lobbyist for Pfizer.
Did anyone really expect that Trump could nominate RFK, Jr. without Bourla’s approval? The day Trump announced he was appointing RFK, Jr. as head of HHS, Pfizer’s stock dropped 10% in value. However, after meeting with Trump and Pfizer CEO Albert Bourla, along with Trump’s chief of staff who also works for Pfizer, Susie Wiles, all of a sudden now RFK, Jr. and Bourla are great friends.
This was just published today by Reuters: PFIZER DOES NOT EXPECT MAJOR VACCINE POLICY CHANGES UNDER TRUMP IN 2025 – Pfizer on Tuesday said it does not expect the Trump administration to make major changes to vaccine policy next year even as the president-elect has put forward vaccine skeptic Robert F. Kennedy Jr. as his nominee to run the Department of Health and Human Services.
Pfizer CEO Albert Bourla told analysts at an investor conference that he had met RFK Jr. and Trump for dinner, confirming earlier media reports, and had developed a good relationship with Kennedy. “If he’s confirmed, we will work with him to make sure that we advance the right policies,” Bourla said.
On Kennedy’s own website, Children’s Health Defense, you will find even worse reports about Bourla and Pfizer (at least for now, until they might take them down as a requirement for Kennedy to be confirmed as HHS head):
Pfizer Has a Long History of Fraud, Corruption and Using Children as Human Guinea Pigs
Big Pharma still dominates lobbying efforts in Washington, D.C., and spends billions each year advertising pharmaceutical products.
Despite the notorious corrupt nature of the pharmaceutical industry, Pfizer’s CEO Albert Bourla claimed during a November 2021 interview that a small group of “medical professionals” who are intentionally circulating “misinformation” critical of the Pfizer vaccine narrative are “criminals.”
LOBBYIST of BIG PHARMA & WEAPONS as WHITE HOUSE Staff Chief. Trump’s First Step into NWO Hell
Bourla seemed to have forgotten about the history of his own company.
Pfizer’s long history of criminal behavior
- In 1992, Pfizer agreed to pay between $165 million and $215 million to settle lawsuits arising from the fracturing of its Bjork-Shiley Convexo-Concave heart valve, which at the time had resulted in nearly 300 deaths, and by 2012 had resulted in 663 deaths.
- In 1994, Pfizer agreed to pay $10.75 million to settle Justice Department claims that the company lied to get federal approval for a mechanical heart valve that has fractured, killing hundreds of patients worldwide.
Under the settlement, Pfizer also agreed to pay $9.25 million in coming years to monitor patients who received the device at Veterans Administration hospitals or pay for its removal.
The deal was criticized by consumer rights activists who urged Government officials to bring criminal charges and lobbied for a steeper civil penalty for the multibillion-dollar company that had covered up safety concerns even as the device was killing patients.
- In 1996, Pfizer administered an experimental drug during a clinical trial on 200 children in Nigeria but never told the parents that their children were the subjects of an experiment. Eleven of the children died, and many others suffered side effects such as brain damage and organ failure.
A report by Nigeria’s health ministry concluded the experiment was “an illegal trial of an unregistered drug,” a “clear case of exploitation of the ignorant,” and a violation of Nigerian and international law. Pfizer did not obtain consent or inform the patients that they were the subjects of an experiment, not the recipients of an approved drug.
- In 2002, Pfizer agreed to pay $49 million to settle allegations that the drug company defrauded the federal government and 40 states by charging too much for its cholesterol treatment Lipitor. Lipitor had sales of $6.45 billion in 2001.
- In 2004, Pfizer agreed to plead guilty to two felonies and paid $430 million in penalties to settle charges that it fraudulently promoted the drug Neurontin for unapproved uses.
Pfizer agreed that it aggressively marketed the epilepsy drug illicitly for unrelated conditions, including bipolar disorder, pain, migraine headaches and drug and alcohol withdrawal. Pfizer’s tactics included planting company operatives in the audience at medical education events and bribing doctors with luxury trips.
- In 2008, the New York Times published an article entitled “Experts Conclude Pfizer Manipulated Studies.” Pfizer delayed the publication of negative studies, spun negative data to place it in a more positive light and controlled the flow of clinical research data to promote its epilepsy drug Neurontin.
Pfizer discontinued its marketing program for Neurontin in 2004 after the drug became available as a generic. That same year, the company paid $430 million to settle federal criminal and civil claims that one of its subsidiaries had promoted the drug for unapproved uses.
- In 2009, Pfizer was fined $2.3 billion, then the largest healthcare fraud settlement and the largest criminal fine ever imposed in the U.S. Pfizer pled guilty to misbranding the painkiller Bextra with “the intent to defraud or mislead,” promoting the drug to treat acute pain at dosages the FDA had previously deemed dangerously high.
The government alleged that Pfizer had paid kickbacks to compliant doctors and also promoted three other drugs illegally: the antipsychotic Geodon, an antibiotic Zyvox and the antiepileptic drug Lyrica.
- In 2009, Pfizer paid $750 million to settle 35,000 claims that its drug, Rezulin, was responsible for 63 deaths and dozens of liver failures. Rezulin’s withdrawal from the U.S. market on March 21, 2000, followed negotiations between the drug’s manufacturer and the FDA.
Senior FDA officials had long stood behind the drug despite a mounting death toll and Rezulin’s absence of proven life-saving benefits. The position of the FDA officials stood in contrast to their counterparts in Britain, where Rezulin was removed effectively on Dec. 1, 1997.
- In 2010, Pfizer was ordered to pay $142.1 million in damages for violating federal anti-racketeering law by its fraudulent sale and marketing of Neurontin for uses not approved by the FDA. The jury found that Pfizer’s marketing of Neurontin violated both the Racketeer Influenced and Corrupt Organizations Act and California’s Unfair Competition Law.
- In 2010, the New York Times published an article entitled “Pfizer Gives Details on Payments to Doctors.” Pfizer admitted that it paid about $20 million to 4,500 doctors and other medical professionals for consulting and speaking on its behalf in the last six months of 2009.
Pfizer also paid $15.3 million to 250 academic medical centers and other research groups for clinical trials in the same period. The disclosures were required by an agreement that the company signed to settle a federal investigation into the illegal promotion of drugs for off-label uses.
BREAKING: Trump picks RFK Jr. for Health and Human Services secretary
- In 2010, Blue Cross Blue Shield filed a lawsuit against Pfizer, accusing the pharmaceutical giant of illegally bribing 5,000 doctors with lavish Caribbean vacations, golf games, massages and other recreational activities to convince doctors to use Bextra for off-label use.
- In 2010, leaked cables between Pfizer and U.S. officials in Nigeria showed that Pfizer had hired investigators to unearth evidence of corruption against the Nigerian attorney general to blackmail him to drop legal action over the controversial 1996 Trovan trial involving children with meningitis.
In 2009, Pfizer agreed to pay $75 million to the families harmed during the 1996 drug trial. Still, the cables suggest that the US drug giant was looking for blackmail to get the Nigerian attorney general to drop the $6 billion federal suit against Pfizer.
The leaks showed that Pfizer’s investigators were passing ‘damaging’ information to the local media and threatening the attorney general that much more damaging information would come out if he did not drop the suit. The $6 billion lawsuit was dropped in 2009.
- In 2012, the Securities and Exchange Commission charged Pfizer Inc. with violating the Foreign Corrupt Practices Act when its subsidiaries bribed doctors and other health care professionals employed by foreign governments in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia and Serbia to win business.
According to the Securities and Exchange Commission, employees of Pfizer’s subsidiaries authorized and made cash payments and provided other incentives to bribe government doctors to utilize Pfizer products.
- In 2012, Pfizer paid $1.2 billion to settle claims by nearly 10,000 women that its hormone replacement therapy drug, Prempro, caused breast cancer. The Prempro settlements came after six years of trials.
Several plaintiffs were awarded tens of millions of dollars, including punitive damages for the drug maker’s actions in withholding information about the risk of breast cancer from Prempro.
- In 2013, Pfizer agreed to pay $55 million to settle criminal charges of failing to warn patients and doctors about the risks of kidney disease, kidney injury, kidney failure and acute interstitial nephritis caused by its proton pump inhibitor, Protonix.
- In 2013, Pfizer set aside $288 million to settle claims by 2,700 people that its drug, Chantix, caused suicidal thoughts and severe psychological disorders. The FDA determined that Chantix is probably associated with a higher risk of a heart attack.
- In 2014, Pfizer paid $35 million to settle a lawsuit accusing its subsidiary of promoting the kidney transplant drug Rapamune for unapproved uses, including bribing doctors to prescribe it to patients.
According to New York Attorney General Eric Schneiderman, who led the probe, Wyeth got doctors to push the drug for unapproved uses, relying on “misleading presentations of data.”
- In 2016, Pfizer was fined a record £84.2 million for overcharging the National Health Service for its anti-epilepsy drug, Phenytoin, by 2,600% (from £2.83 to £67.50 a capsule), increasing the cost to U.K. taxpayers from £2 million in 2012 to about £50 million in 2013.
The above is only a partial list of the fraud, corruption and criminality of Pfizer. There are other examples of Pfizer unethically testing pharmaceutical products in the world’s poorest nations and participating in other criminal actions. (Full article. Archived here.)
The day Trump announced he was appointing RFK, Jr. as head of HHS, Pfizer’s stock dropped 10% in value.
However, after meeting with Trump and Pfizer CEO Albert Bourla, along with Trump’s chief of staff who also works for Pfizer, Susie Wiles, all of a sudden now RFK, Jr. and Bourla are great friends.
This was just published today by Reuters:
Pfizer does not expect major vaccine policy changes under Trump in 2025
Pfizer on Tuesday said it does not expect the Trump administration to make major changes to vaccine policy next year even as the president-elect has put forward vaccine skeptic Robert F. Kennedy Jr. as his nominee to run the Department of Health and Human Services.
Pfizer CEO Albert Bourla told analysts at an investor conference that he had met RFK Jr. and Trump for dinner, confirming earlier media reports, and had developed a good relationship with Kennedy.
RFK jr’s BETRAYAL of ANTI-VAX! He will Join Forces with Trump-Vance, Moderna Big Pharma partners
“If he’s confirmed, we will work with him to make sure that we advance the right policies,” Bourla said. (Full article.)
And people in the “Alternative Media” have been foolishly publishing lies about how RFK, Jr. is going to go to Washington D.C. to put Big Pharma in their place, including Children’s Health Defense which is using Kennedy’s appointment to raise more money.
READ MORE DETAILS ON HEALTH IMPACT NEWS
by Brian Shilhavy – originally published on Health Impact News
Pfizer CEO says he developed ‘good relation’ with RFK Jr., highlights Trump’s pride in vaccine work
excerpt by Angus Liu – originally published on Fierce Pharma
As one of the largest vaccine makers, Pfizer has a big part of its business hinging on potential immunization policy changes under the incoming Trump administration. So when vaccine skeptic Robert F. Kennedy Jr. was offered the top job at the Department of Health and Human Services, Pfizer CEO Albert Bourla knew he had to meet the possible health czar.
Bourla on Tuesday confirmed his recent dinner with Trump at the President-elect’s Mar-a-Lago residence, along with RFK Jr. Eli Lilly’s CEO David Ricks was also in attendance.
“I don’t want to speak about the details of what we discussed during that dinner because I want to respect the privacy, but we developed a good relation with Mr. Kennedy,” Bourla said during an investor call Tuesday.
“If he’s confirmed, we will work with him to make sure that we advance the right policies,” Bourla said, adding that Pfizer is interested in policies, not politics.
As an antivaccine activist, RFK Jr. has propelled debunked theories that blame vaccines for autism and other chronic diseases. When his HHS nomination was announced, Pfizer’s stock price—along with the share prices of several other vaccine makers—dropped.
But the new HHS pick himself recently said that he’s “not going to take anyone’s vaccines away from them.” So it still remains unclear just how—if at all—the new administration would limit or discourage vaccination.
5 Scientific Findings Explain Link Between Vaccines and Autism
Without commenting on RFK Jr.’s thinking, Pfizer’s Bourla on Tuesday instead focused on his “very long-lasting relationship” with President Trump, spanning back to the president’s prior term.
“The President is extremely proud, and of course, we are extremely proud, that [Pfizer] basically delivered a vaccine through this landmark golden standard program, the Operation Warp Speed […] that saved millions of lives,” Bourla said.
excerpt by Angus Liu – originally published on Fierce Pharma
